296 related articles for article (PubMed ID: 16418514)
1. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 mutation carriers, reproductive factors and breast cancer risk.
Tryggvadottir L; Olafsdottir EJ; Gudlaugsdottir S; Thorlacius S; Jonasson JG; Tulinius H; Eyfjord JE
Breast Cancer Res; 2003; 5(5):R121-8. PubMed ID: 12927042
[TBL] [Abstract][Full Text] [Related]
3. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
4. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
6. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees.
Baffoe-Bonnie AB; Beaty TH; Bailey-Wilson JE; Kiemeney LA; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
Genet Epidemiol; 2000 Jan; 18(1):81-94. PubMed ID: 10603460
[TBL] [Abstract][Full Text] [Related]
8. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
King MC; Marks JH; Mandell JB;
Science; 2003 Oct; 302(5645):643-6. PubMed ID: 14576434
[TBL] [Abstract][Full Text] [Related]
9. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Metcalfe K; Lynch HT; Ghadirian P; Tung N; Olivotto I; Warner E; Olopade OI; Eisen A; Weber B; McLennan J; Sun P; Foulkes WD; Narod SA
J Clin Oncol; 2004 Jun; 22(12):2328-35. PubMed ID: 15197194
[TBL] [Abstract][Full Text] [Related]
10. BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
Rafnar T; Benediktsdottir KR; Eldon BJ; Gestsson T; Saemundsson H; Olafsson K; Salvarsdottir A; Steingrimsson E; Thorlacius S
Eur J Cancer; 2004 Dec; 40(18):2788-93. PubMed ID: 15571962
[TBL] [Abstract][Full Text] [Related]
11. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
[TBL] [Abstract][Full Text] [Related]
12. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
13. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.
Pääkkönen K; Sauramo S; Sarantaus L; Vahteristo P; Hartikainen A; Vehmanen P; Ignatius J; Ollikainen V; Kääriäinen H; Vauramo E; Nevanlinna H; Krahe R; Holli K; Kere J
Genet Epidemiol; 2001 Feb; 20(2):239-46. PubMed ID: 11180449
[TBL] [Abstract][Full Text] [Related]
14. The genetic attributable risk of breast and ovarian cancer.
Claus EB; Schildkraut JM; Thompson WD; Risch NJ
Cancer; 1996 Jun; 77(11):2318-24. PubMed ID: 8635102
[TBL] [Abstract][Full Text] [Related]
15. Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations.
Marroni F; Aretini P; D'Andrea E; Caligo MA; Cortesi L; Viel A; Ricevuto E; Montagna M; Cipollini G; Federico M; Santarosa M; Marchetti P; Bailey-Wilson JE; Bevilacqua G; Parmigiani G; Presciuttini S
Eur J Hum Genet; 2004 Nov; 12(11):899-906. PubMed ID: 15340362
[TBL] [Abstract][Full Text] [Related]
16. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
Kaufman DJ; Beaty TH; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
[TBL] [Abstract][Full Text] [Related]
17. Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families.
Barkardottir RB; Sarantaus L; Arason A; Vehmanen P; Bendahl PO; Kainu T; Syrjäkoski K; Krahe R; Huusko P; Pyrhönen S; Holli K; Kallioniemi OP; Egilsson V; Kere J; Nevanlinna H
Eur J Hum Genet; 2001 Oct; 9(10):773-9. PubMed ID: 11781689
[TBL] [Abstract][Full Text] [Related]
18. Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.
Gong G; Whittemore AS
Genet Epidemiol; 2003 Apr; 24(3):173-80. PubMed ID: 12652521
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 mutations in 154 finnish male breast cancer patients.
Syrjäkoski K; Kuukasjärvi T; Waltering K; Haraldsson K; Auvinen A; Borg A; Kainu T; Kallioniemi OP; Koivisto PA
Neoplasia; 2004; 6(5):541-5. PubMed ID: 15548363
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
